A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2011
09/29/2011	US20110238000 Polymer-conjugated albumin hydrogels for controlled release of therapeutic agents
09/29/2011	US20110237858 Device and Methods for Sequential, Regional Delivery of Multiple Cytotoxic Agents and Directed Assembly of Wound Repair Tissues
09/29/2011	US20110237811 Stabilized steroid composition and method for its preparation
09/29/2011	US20110237792 Quinoline derivatives and their use as 5-ht6 ligands
09/29/2011	US20110237783 Hydrazonopyrazole derivatives and their use as therapeutics
09/29/2011	US20110237682 S1p receptor modulators for treating mutiple sclerosis
09/29/2011	US20110237681 Inhalable epinephrine
09/29/2011	US20110237680 Crystal forms of o-desmethylvenlafaxine fumarate
09/29/2011	US20110237679 Novel antiviral compounds, compositions, and methods of use
09/29/2011	US20110237677 Inhibitors
09/29/2011	US20110237676 Spermicidal and microbicidal compositions
09/29/2011	US20110237675 Pharmaceutical formulations
09/29/2011	US20110237674 Topical nsaid compositions having sensate component
09/29/2011	US20110237673 Novel NIDDM Regimen
09/29/2011	US20110237672 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production
09/29/2011	US20110237671 Cosmetic composition comprising vitamin u as active ingredient for healing wounds and reducing wrinkles
09/29/2011	US20110237670 Improvement of normal cognitive function
09/29/2011	US20110237669 Polyunsaturated Fatty Acids Interactions and Oxidative Stress Disorders
09/29/2011	US20110237668 Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
09/29/2011	US20110237667 Compositions Containing Diethanol Amine Esterquats
09/29/2011	US20110237666 Hydroxybutyrate ester and medical use thereof
09/29/2011	US20110237664 Selective androgen receptor modulators for treating diabetes
09/29/2011	US20110237663 Method for treating Philadelphia-negative myeloproliferative syndromes
09/29/2011	US20110237662 Use of Statins to Inhibit Inflammation and Vascular Disease
09/29/2011	US20110237661 Supplement Composition and Method of Use
09/29/2011	US20110237660 Oral composition
09/29/2011	US20110237659 Chromenone derivatives as trpv3 antagonists
09/29/2011	US20110237658 Compound and method for the treatment of pain
09/29/2011	US20110237657 Transport-Mediating Colloidal Pharmaceutical Compounds
09/29/2011	US20110237656 Method of Selectively Inhibiting the Activity of ACAT1 in the Treatment of Alzheimer's Disease
09/29/2011	US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
09/29/2011	US20110237654 Method to inhibit cell growth using oligonucleotides
09/29/2011	US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
09/29/2011	US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/29/2011	US20110237649 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
09/29/2011	US20110237648 Rna interference in skin indications
09/29/2011	US20110237647 Inhibitory rna for modulating the molecular function of zfat gene
09/29/2011	US20110237646 Modulation of transthyretin expression for the treatment of cns related disorders
09/29/2011	US20110237645 USE OF RNAi TECHNOLOGY TO INHIBIT ASIC3
09/29/2011	US20110237644 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof
09/29/2011	US20110237643 Identification of a Novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity
09/29/2011	US20110237642 Process for Forming Amorphous Atorvastatin
09/29/2011	US20110237641 Substituted pyrazoles, compositions containing these, method of production and use
09/29/2011	US20110237640 Pyrazole phenyl derivatives
09/29/2011	US20110237639 Imidazolinylmethyl aryl sulfonamide
09/29/2011	US20110237638 Metronidazole-based dermatological foam and emulsions for the preparation thereof
09/29/2011	US20110237637 Metronidazole-based dermatological foam and emulsions for the production thereof
09/29/2011	US20110237636 Hepatitis C Virus Inhibitors
09/29/2011	US20110237635 Tetrahydronaphthalene derivatives
09/29/2011	US20110237634 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1
09/29/2011	US20110237633 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/29/2011	US20110237631 Selective Glycosidase Inhibitors and Uses Thereof
09/29/2011	US20110237630 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
09/29/2011	US20110237629 Amino acid ester prodrugs and the use thereof
09/29/2011	US20110237628 Cyclopentyl- and cycloheptylpyrazoles
09/29/2011	US20110237627 Methods of synthesizing anatabine
09/29/2011	US20110237625 SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-á MODULATORS
09/29/2011	US20110237624 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
09/29/2011	US20110237623 Sustained-release donepezil formulation
09/29/2011	US20110237622 Renin inhibitors
09/29/2011	US20110237621 Macrocyclic Inhibitors of Hepatitis C Virus
09/29/2011	US20110237620 Heterocyclic compound and use thereof
09/29/2011	US20110237619 Imidazopyridine derivatives which inhibit the secretion of gastric acid
09/29/2011	US20110237618 Methods for treating migraines with huperzine a derivatives
09/29/2011	US20110237617 Thieno[2,3-c] isoquinolines for use as inhibitors of parp
09/29/2011	US20110237616 Phehylephrine formulations with improveds stability
09/29/2011	US20110237615 Narcotic Drug Formulations with Decreased Abuse Potential
09/29/2011	US20110237614 Pegylated Opioids with Low Potential for Abuse
09/29/2011	US20110237613 Dha esters and use thereof in treatment and prevention of cardiovascular disease
09/29/2011	US20110237611 Chemical permeation enhancers enhance nerve blockade by toxins
09/29/2011	US20110237610 Quinazoline Derivatives as Antiproliferative Agents
09/29/2011	US20110237609 Antifolate compositions
09/29/2011	US20110237608 Pyridopyrimidinone Inhibitors of PI3Kalpha
09/29/2011	US20110237607 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
09/29/2011	US20110237606 3-Deazaneplanocin Derivatives
09/29/2011	US20110237605 Molecular Crystal of (4-(1,8-Naphthyridin-2-YL)Piperidin-1-YL)Pyrimidine Derivative
09/29/2011	US20110237604 Methods for preventing or treating cardiac arrhythmia
09/29/2011	US20110237603 Compositions of azimilide dihydrochloride
09/29/2011	US20110237602 Method for treating schizophrenia and related diseases
09/29/2011	US20110237601 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
09/29/2011	US20110237600 Compounds for improving learning and memory
09/29/2011	US20110237599 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/29/2011	US20110237598 New compounds
09/29/2011	US20110237597 Method of treating peripheral nerve sensory loss using compounds having nicotinic acetylcholine receptor activity
09/29/2011	US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
09/29/2011	US20110237595 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
09/29/2011	US20110237593 Topical anti-pruritic compositions and methods of action of same
09/29/2011	US20110237592 Substituted amido phenoxybenzamides
09/29/2011	US20110237590 Pyridine-3-carboxyamide derivative
09/29/2011	US20110237589 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/29/2011	US20110237587 1,3,5-Triazine-2,4,6-Triamine Compound or Pharmaceutical Acceptable Salt Thereof, and Pharmaceutical Composition Comprising the Same
09/29/2011	US20110237586 Biaryl compositions and methods for modulating a kinase cascade
09/29/2011	US20110237585 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
09/29/2011	US20110237584 Kynurenine production inhibitor
09/29/2011	US20110237583 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
09/29/2011	US20110237582 Pyrido[3,4-b]indoles and methods of use
09/29/2011	US20110237581 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
09/29/2011	US20110237580 Substituted bicyclic imidazole derivatives as gamma secretase modulators
09/29/2011	US20110237579 Inhibitors of hcv ns5a
09/29/2011	US20110237578 Amide compounds, compositions and uses thereof

1 ... 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 ... 7860